Literature DB >> 26758758

Radiation dose and checkpoint blockade immunotherapy: unanswered questions.

Arta M Monjazeb1, Jonathan D Schoenfeld2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26758758     DOI： 10.1016/S1470-2045(15)00541-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  6 in total

Review 1.  Shining light on advanced NSCLC in 2017: combining immune checkpoint inhibitors.

Authors:  Meng Qiao; Tao Jiang; Caicun Zhou
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 2.  The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.

Authors:  Miles Piper; Adam C Mueller; Sana D Karam
Journal:  Mol Carcinog       Date:  2020-05-04       Impact factor: 4.784

3.  Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.

Authors:  Shelby Lennon; Ayman Oweida; Dallin Milner; Andy V Phan; Shilpa Bhatia; Benjamin Van Court; Laurel Darragh; Adam C Mueller; David Raben; Jorge L Martínez-Torrecuadrada; Todd M Pitts; Hilary Somerset; Kimberly R Jordan; Kirk C Hansen; Jason Williams; Wells A Messersmith; Richard D Schulick; Philip Owens; Karyn A Goodman; Sana D Karam
Journal:  Clin Cancer Res       Date:  2019-04-03       Impact factor: 12.531

Review 4.  Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.

Authors:  Laurel B Darragh; Ayman J Oweida; Sana D Karam
Journal:  Front Immunol       Date:  2019-01-31       Impact factor: 7.561

5.  A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer.

Authors:  Arta M Monjazeb; Anita Giobbie-Hurder; Ana Lako; Emily M Thrash; Ryan C Brennick; Katrina Z Kao; Claire Manuszak; Ryan D Gentzler; Anteneh Tesfaye; Salma K Jabbour; Olatunji B Alese; Osama E Rahma; James M Cleary; Elad Sharon; Harvey J Mamon; May Cho; Howard Streicher; Helen X Chen; Mansoor M Ahmed; Adrian Mariño-Enríquez; Seunghee Kim-Schulze; Sacha Gnjatic; Emanual Maverakis; Alina I Marusina; Alexander A Merleev; Mariano Severgnini; Kathleen L Pfaff; James Lindsay; Jason L Weirather; Srinika Ranasinghe; Alexander Spektor; Scott J Rodig; Stephen F Hodi; Jonathan D Schoenfeld
Journal:  Clin Cancer Res       Date:  2021-02-10       Impact factor: 13.801

Review 6.  Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination.

Authors:  Jun Gong; Thang Q Le; Erminia Massarelli; Andrew E Hendifar; Richard Tuli
Journal:  J Immunother Cancer       Date:  2018-06-04       Impact factor: 13.751
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.